| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.6 | 0.001 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.57 | 0.003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.56 | 0.006 |